NRG1 and cancer: On the other hand, the CAFs-derived NRG1 (SE = 3.6) activation of cancer cell ERBB2 and ERBB3 receptor tyrosine kinases as a paracrine mechanism supports mutant KRAS-independent growth (Figure 4) [57].